Flexzo AI Closes $12M Series A to Optimize Hospital Workforces
  • News
  • Europe

Flexzo AI Closes $12 million Series A to Optimize Hospital Workforces

Led by Octopus Ventures, the round will fuel the AI platform's expansion across the UK and US.

3/20/2026
Ali Abounasr El Alaoui
Back to News

Flexzo AI, a UK-based health-tech startup, has successfully closed a $12 million Series A funding round to advance its agentic AI workforce system. The investment, led by Octopus Ventures with participation from Fuel Ventures, will fuel the company's expansion across the UK's National Health Service and into the United States market. This capital injection marks a significant milestone in the company's mission to modernize healthcare staffing.


Addressing Systemic Healthcare Staffing Challenges

Healthcare organizations have long struggled with chronic staff shortages and escalating costs associated with temporary agency workers. Flexzo AI, founded in 2023 by CEO Jack Henderson, was established to confront these deep-rooted inefficiencies head-on. The company aims to provide a sustainable alternative to outdated workforce management practices that strain hospital budgets and operational capacity.

Henderson's direct experience with the complexities of clinical insourcing revealed how fragmented workflows and poor visibility hinder safe and cost-effective staffing. Traditional reliance on agencies often leads to spiraling expenses without addressing the core issues of workforce optimization. Flexzo AI's platform was designed to deliver a fundamental shift, offering the efficiency that the healthcare system urgently requires.

An Innovative AI-Driven Solution

Flexzo AI introduces a subscription-based platform that provides hospitals with direct access to a national talent pool and advanced workforce tools. This model circumvents the high markups and placement fees typically charged by traditional staffing agencies. By connecting hospitals directly with pre-verified professionals, the system significantly lowers workforce supply costs and improves transparency.

The platform integrates several critical systems tailored for complex hospital environments, including dynamic rostering and staff bank management tools. It also features collaborative technology to connect teams across different departments and sites, maximizing the use of internal staff. This holistic approach ensures that workforce deployment is optimized for both cost and clinical need.

The Power of Agentic AI and Proactive Sourcing

At the core of Flexzo's technology is an agentic AI matching engine that automates complex staffing decisions. The system identifies workforce gaps, validates clinician compliance in real time, and routes staffing requests to the most appropriate and cost-effective option. This intelligent automation ensures the right professional is deployed to the right area with enhanced operational oversight.

A key feature, Flexzo Amplify, actively reduces dependency on external agencies over time by treating each agency use as a signal of a workforce gap. The system then automatically sources and onboards new clinicians from the broader market, continuously strengthening the hospital's direct talent pipeline. This proactive approach ensures the platform becomes more robust and self-sufficient with every use.

Strategic Investment and Future Growth

The Series A round brings new expertise to the company's leadership, with Uthish Ranjan of Octopus Ventures and Shiv Patel of Fuel Ventures joining the board of directors. Additionally, Professor Rupert Shute, a former government scientific advisor, has been appointed as Non-Executive Chairman. This strategic backing strengthens the company's governance and industry knowledge as it prepares for its next phase of growth.

With this new capital, Flexzo AI plans to accelerate its rollout to more NHS Trusts and expand its international presence, having already secured its first clients in the United States. The company will also invest in its team to enhance product features and further develop its agentic AI models for more complex clinical settings. The funding will bolster implementation capacity to meet the growing demand for its innovative solution.


Flexzo AI's successful funding round highlights a significant shift towards technology-driven solutions for healthcare's persistent workforce challenges. The company's impressive results, including reducing agency spend by up to 85% at partner sites, demonstrate the tangible impact of its platform. As Flexzo AI expands its reach, it is well-positioned to lead a global transformation in creating a more efficient and sustainable healthcare ecosystem.